Literature DB >> 21860426

MicroRNA-mediated upregulation of integrin-linked kinase promotes Src-induced tumor progression.

C Oneyama1, E Morii, D Okuzaki, Y Takahashi, J Ikeda, N Wakabayashi, H Akamatsu, M Tsujimoto, T Nishida, K Aozasa, M Okada.   

Abstract

The tyrosine kinase c-Src is upregulated in various human cancers; however, the molecular mechanisms underlying c-Src-mediated tumor progression remain unclear. Here we show that downregulation of microRNA (miR)-542-3p is tightly associated with tumor progression via c-Src-related oncogenic pathways. In c-Src-transformed fibroblasts and human cancer cells that overexpress c-Src, miR-542-3p is substantially downregulated, and the ectopic expression of miR-542-3p suppresses tumor growth. We identified the integrin-linked kinase (ILK) as a conserved target of miR-542-3p. ILK upregulation promotes cell adhesion and invasion by activating the integrin-focal adhesion kinase (FAK)/c-Src pathway, and can also contribute to tumor growth via the AKT and glycogen synthase kinase 3β pathways. MiR-542-3p expression is downregulated by the activation of c-Src-related signaling molecules, including epidermal growth factor receptor, K-Ras and Ras/Raf/mitogen-activated protein kinase/extracellular signal-regulated kinase. In human colon cancer tissues, downregulation of miR-542-3p is significantly correlated with the upregulation of c-Src and ILK. Our results suggest that the novel c-Src-miR-542-3p-ILK-FAK circuit plays a crucial role in controlling tumor progression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21860426     DOI: 10.1038/onc.2011.367

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  34 in total

1.  p53 is positively regulated by miR-542-3p.

Authors:  Yemin Wang; Jen-Wei Huang; Maria Castella; David George Huntsman; Toshiyasu Taniguchi
Journal:  Cancer Res       Date:  2014-04-24       Impact factor: 12.701

2.  MicroRNA-542-3p suppresses cell growth of gastric cancer cells via targeting oncogene astrocyte-elevated gene-1.

Authors:  Xinsheng Shen; Yaqing Si; Zhugong Yang; Qun Wang; Jiaxiang Yuan; Xiefu Zhang
Journal:  Med Oncol       Date:  2014-11-29       Impact factor: 3.064

3.  Fer tyrosine kinase oligomer mediates and amplifies Src-induced tumor progression.

Authors:  C Oneyama; Y Yoshikawa; Y Ninomiya; T Iino; S Tsukita; M Okada
Journal:  Oncogene       Date:  2015-04-13       Impact factor: 9.867

4.  SRC points the way to biomarkers and chemotherapeutic targets.

Authors:  Harini Krishnan; W Todd Miller; Gary S Goldberg
Journal:  Genes Cancer       Date:  2012-05

5.  MicroRNA-542-3p Suppresses Tumor Cell Invasion via Targeting AKT Pathway in Human Astrocytoma.

Authors:  Junchao Cai; JingJing Zhao; Nu Zhang; Xiaonan Xu; Rong Li; Yang Yi; Lishan Fang; Le Zhang; Mengfeng Li; Jueheng Wu; Heng Zhang
Journal:  J Biol Chem       Date:  2015-08-18       Impact factor: 5.157

6.  Role of miRNA dynamics and cytokine profile in governing CD44v6/Nanog/PTEN axis in oral cancer: modulating the master regulators.

Authors:  Shanaya Patel; Rakesh Rawal
Journal:  Tumour Biol       Date:  2016-09-09

7.  In silico analysis of pathways affected by differentially expressed microRNA in adrenocortical tumors.

Authors:  A Zsippai; P M Szabó; D R Szabó; Z Nagy; A Patócs; K Rácz; P Igaz
Journal:  J Endocrinol Invest       Date:  2013-07-01       Impact factor: 4.256

8.  Overexpression of integrin-linked kinase promotes lung cancer cell migration and invasion via NF-κB-mediated upregulation of matrix metalloproteinase-9.

Authors:  Mingjing Zhao; Ying Gao; Lingling Wang; Shuo Liu; Bing Han; Lie Ma; Yuan Ling; Shitao Mao; Xiaoge Wang
Journal:  Int J Med Sci       Date:  2013-06-14       Impact factor: 3.738

9.  In silico investigation of potential SRC kinase ligands from traditional Chinese medicine.

Authors:  Weng Ieong Tou; Calvin Yu-Chian Chen
Journal:  PLoS One       Date:  2012-03-21       Impact factor: 3.240

10.  MicroRNA-143 targets MACC1 to inhibit cell invasion and migration in colorectal cancer.

Authors:  Yu Zhang; Zhongqiu Wang; Min Chen; Liang Peng; Xinying Wang; Qunying Ma; Fengli Ma; Bo Jiang
Journal:  Mol Cancer       Date:  2012-04-25       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.